Biopharma’s first fully integrated data asset
Paving the way for breakthroughs in drug development and commercialization so you can get closer to the patient than ever before—and bring life-changing therapies to market faster.
74 billion data points.
NorstellaLinQ is the first and only fully integrated data asset combining real-world data and Norstella’s proprietary intelligence from the most trusted brands in the industry – Citeline, Evaluate, MMIT, Panalgo and The Dedham Group.
We’re setting a new standard for data integration by combining real-world data including open and closed claims, lab results, and electronic medical records with Norstella’s proprietary forecasting, clinical, regulatory, payer, and commercial intelligence data. This comprehensive approach from the most trusted brands in the industry helps you find the fastest path from pipeline to patient.
Empowering teams across the product lifecycle
NorstellaLinQ gives your teams access to better data and stronger insights so they can make rapid, confident, data-driven decisions while eliminating human error and bias.
Fusing machine learning, AI, and decades of historical data, NorstellaLinQ’s predictive capabilities are supported by hundreds of MDs, epidemiologists, PhDs, pharmacists, technologists and data scientists.
Clinical operations teams
Optimize protocol design, site and investigator selection.
Clinical trial teams
Identify and recruit medically complex
patients into treatment.
Brand teams
Anticipate patient behavior using predictive analytics to identify clinical symptoms, enabling earlier diagnosis.
Pharma teams
Understand clinical decision making sentiment and impact of patient adherence on clinical outcomes, reimbursement challenges, or denials by analyzing physician notes.
HEOR and epidemiology teams
Generate evidence for improved patient outcomes and cost benefit analysis from the largest patient-level dataset.
Commercial teams
Reach physicians treating specific conditions by hyper targeting patients with varying clinical criteria.
Market access teams
Track time to treatment in areas of restrictive behavior and advocate for open access speeding time to therapy.
Meet our real-world data experts
Norstella’s real-world data specialists have extensive experience in leveraging structured and unstructured healthcare data to power insights across commercial, medical affairs, HEOR, and clinical trial engagement.
Unparalleled data. Unmatched expertise.
When you choose NorstellaLinQ, you gain access to the industry’s most comprehensive proprietary and patient data, supported by an expert team of MDs, epidemiologists, PhDs, pharmacists, technologists and data scientists dedicated to driving better outcomes.
With AI-driven insights that simplify decision-making, NorstellaLinQ reduces complexity, accelerates processes, and delivers actionable recommendations. Its patient-centered analysis helps you get closer to patients and the treatments they need, faster.
use case
Revealing hidden patient populations to optimize targeting strategies
In this use case, find out how MMIT, using NorstellaLinQ, helped one manufacturer improve disease-state education and guide more effective account-level targeting by isolating specific patient cohorts with structured and unstructured EMR data.
Infographic
LinQNotes: Get the “why” behind treatment decisions
Download the infographic to learn how LinQNotes uses hidden EMR insights to fuel better patient outcomes.
use case
Integrated data and analytic expertise for a competitive edge in the breast cancer market
In this use case, find out how MMIT, using NorstellaLinQ, used real-world data to deliver insights to support a breast cancer drug’s strategic positioning, market evolution, and long-term growth planning.
use case
Gain real-time insights on high-risk patient populations with real-world data
In this use case, find out how MMIT, using NorstellaLinQ, used real-world data to help a manufacturer specializing in multiple myeloma therapies get a clearer picture of high-risk patients and the physicians treating them.
infographic
Illuminating the rare disease journey
Download the full infographic to see how NorstellaLinQ gives you a fuller data picture to drive commercial impact and bring you closer to rare disease patients.
use case
Empowering early disease diagnosis with real-world data
In this use case, find out how MMIT, using NorstellaLinQ, merged unstructured EMR data with structured data to help a global pharma company detect disease screening patterns and drive commercialization strategies.
use case
Refining rare disease targeting with real-world data
In this use case, learn how MMIT, using NorstellaLinQ, identified a narrower patient population and improved the client’s physician targeting.
use case
Targeting patients and fueling brand strategy with trigger alerts
In this use case, find out how MMIT, using NorstellaLinQ, helped a pharma company identify high-risk patients with Trigger Alerts.
use case
Addressing cost barriers and enhancing medicare access strategies to improve commercialization strategy
In this use case, learn how MMIT, powered by NorstellaLinQ, translated complex RWD into actionable insights which helped the client tackle affordability and access challenges in a complex therapeutic area.
use case
Complex cohort identification fuels real-time HCP targeting
Learn how one manufacturer used integrated claims, lab, EMR and coverage data to identify newly diagnosed, early-stage cancer patients for just-in-time HCP targeting.
case study
Unstructured EMR Data Expands Cohort Identification by 1,500%
By using integrated EMR, lab and claims data, Panalgo was able to provide the manufacturer with a rich longitudinal history for all identified patients.
case study
Powering Unbiased Outcomes Research with Longitudinal Data
Within eight weeks, the client had access to years of longitudinal arthroplasty data, representing both inpatient and outpatient procedures, to fuel its study.
